These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24864657)

  • 1. Intestinal microbiota produced trimethylamine-N-oxide can increase the risk of cardiovascular disease.
    Khan MS; Bawany FI; Khan A
    J Pak Med Assoc; 2014 Apr; 64(4):488. PubMed ID: 24864657
    [No Abstract]   [Full Text] [Related]  

  • 2. What Are Missing Parts in the Research Story of Trimethylamine-N-oxide (TMAO)?
    He Z; Chen ZY
    J Agric Food Chem; 2017 Jul; 65(26):5227-5228. PubMed ID: 28650144
    [No Abstract]   [Full Text] [Related]  

  • 3. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide.
    Al-Rubaye H; Perfetti G; Kaski JC
    Curr Probl Cardiol; 2019 Jun; 44(6):182-196. PubMed ID: 30482503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.
    Brown JM; Hazen SL
    Annu Rev Med; 2015; 66():343-59. PubMed ID: 25587655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.
    Drosos I; Tavridou A; Kolios G
    Metabolism; 2015 Apr; 64(4):476-81. PubMed ID: 25676802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. You Are What You Eat: Metabolites of Gut Microbiota Provide Novel Insights into Diagnosis and Development of Chronic Kidney Disease.
    Quante M
    Transplantation; 2015 Jul; 99(7):1306-7. PubMed ID: 26147133
    [No Abstract]   [Full Text] [Related]  

  • 9. Gut microbiota: an environmental risk factor for cardiovascular disease.
    Stock J
    Atherosclerosis; 2013 Aug; 229(2):440-2. PubMed ID: 23880200
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
    Tang WH; Hazen SL
    Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Microbiota Metabolism and Atherosclerosis.
    Liu TX; Niu HT; Zhang SY
    Chin Med J (Engl); 2015 Oct; 128(20):2805-11. PubMed ID: 26481750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cardiovascular disease: a cautionary tale of diet-microbiome interactions.
    Miller MJ
    J Am Coll Nutr; 2013; 32(2):75-8. PubMed ID: 24015714
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut flora, diet and intestinal metabolism on cardiovascular risk.
    Bhatnagar D
    Curr Opin Lipidol; 2015 Apr; 26(2):148-9. PubMed ID: 25756810
    [No Abstract]   [Full Text] [Related]  

  • 14. The gut-blood barrier permeability - A new marker in cardiovascular and metabolic diseases?
    Ufnal M; Pham K
    Med Hypotheses; 2017 Jan; 98():35-37. PubMed ID: 28012600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors: intestinal microbiota: "a new direction in cardiovascular research".
    Lim GB
    Nat Rev Cardiol; 2013 Jul; 10(7):363. PubMed ID: 23670614
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of intestinal microbiota in patients with heart failure: A systematic review.
    Formiga F; Ferreira Teles CI; Chivite D
    Med Clin (Barc); 2019 Nov; 153(10):402-409. PubMed ID: 31416611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota, the genome, and diet in atherogenesis.
    Loscalzo J
    N Engl J Med; 2013 Apr; 368(17):1647-9. PubMed ID: 23614591
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the intestinal microbiome on constituents of red meat and egg yolks: a new window opens on nutrition and cardiovascular disease.
    Spence JD
    Can J Cardiol; 2014 Feb; 30(2):150-1. PubMed ID: 24461914
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimethylamine N-oxide variation in humans: the product of a diet-microbiota interaction?
    Tilves C; Mueller NT
    Am J Clin Nutr; 2021 Jun; 113(6):1400-1401. PubMed ID: 33876195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.